Literature DB >> 7517360

B cells from CBA/N mice do not proliferate following ligation of CD40.

J Hasbold1, G G Klaus.   

Abstract

The CBA/N mouse carries the X-linked immunodeficiency xid, resulting in defective B cell development. B cells from these animals cannot mount antibody responses to type 2 T-independent antigens, and do not synthesize DNA when stimulated with anti-immunoglobulin (Ig) antibodies which are mitogenic for normal B cells. The primary antibody responses of CBA/N mice to T-dependent antigens have also been reported to be abnormal. Here we describe the results of experiments which demonstrate that the B cells from these animals respond abnormally to ligation of CD40, a B cell surface molecule now known to play a key role during T cell-B cell interactions, via its interaction with the counterligand (CD40L) expressed by activated T cells. Hence, xid B cells fail to proliferate when cultured with preactivated T helper type 2 (Th2)T cells (known to express CD40L), with a soluble CD40L-CD8 fusion protein, or in response to monoclonal antibodies to CD40, even in the presence of IL-4 and/or anti-Ig reagents. However, xid B cells do receive abortive activation signals following ligation of CD40, as manifested by up-regulation of class II major histocompatibility complex and CD23 antigens. Since the xid defect has now been identified as a point mutation in the protein tyrosine kinase Btk, our results point to an important role for this kinase in the downstream signaling cascade elicited in response to ligation of either surface Ig or CD40.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517360     DOI: 10.1002/eji.1830240123

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  In situ detection of activated Bruton's tyrosine kinase in the Ig signaling complex by phosphopeptide-specific monoclonal antibodies.

Authors:  S Nisitani; R M Kato; D J Rawlings; O N Witte; M I Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

2.  An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.

Authors:  J S Anderson; M Teutsch; Z Dong; H H Wortis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 3.  Clinical targeting of mutated and wild-type protein tyrosine kinases in cancer.

Authors:  Justin M Drake; John K Lee; Owen N Witte
Journal:  Mol Cell Biol       Date:  2014-02-24       Impact factor: 4.272

4.  Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.

Authors:  H B Gaspar; T Lester; R J Levinsky; C Kinnon
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

5.  Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage.

Authors:  R W Hendriks; M F de Bruijn; A Maas; G M Dingjan; A Karis; F Grosveld
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

Review 6.  Cells and cytokines in the pathogenesis of MAIDS, a retrovirus-induced immunodeficiency syndrome of mice.

Authors:  H C Morse; N Giese; R Morawetz; Y Tang; R Gazzinelli; W K Kim; S Chattopadhyay; J W Hartley
Journal:  Springer Semin Immunopathol       Date:  1995

7.  Activation of NF-kappaB/Rel by CD40 engagement induces the mouse germ line immunoglobulin Cgamma1 promoter.

Authors:  S C Lin; J Stavnezer
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

8.  Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia.

Authors:  Cornelia Brunner; Hans Wolfgang Kreth; Hans D Ochs; Volker Schuster
Journal:  J Clin Immunol       Date:  2002-07       Impact factor: 8.317

9.  CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor alpha chain: synergistic effects with interleukin 5.

Authors:  Y Kikuchi; T Yasue; K Miyake; M Kimoto; K Takatsu
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

10.  B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes.

Authors:  H H Wortis; M Teutsch; M Higer; J Zheng; D C Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.